InvestorsHub Logo
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Re: shipbuilder post# 193459

Monday, 10/13/2014 5:09:16 PM

Monday, October 13, 2014 5:09:16 PM

Post# of 345991
shipbuilder, I just hope that PPHM doesn't put any other effort in EBOLA then delivering Bavi to whatever party that may require it to mix it in some EBOLA cocktail. Ethically they cannot let patients hang to dry if Bavi would be of any help.

It would be great if PPHM would concentrate on SUNRISE and I think they do.

Do you have any idea what an effort it is to write a BLA? That is what they should be doing so that when we have results a project procedure can be executed step by step under the lead of an excellent project manager to fill in the blanks, complete it and file it as final.

All other parts should have been discussed upfront as became possible by the Fast Track. We have a Fast Track so its value lies in using it NOW during the trial because that interaction possibility that it grants is its biggest value.

Let's leave Ebola for others and just allow Bavituximab in the cocktail if that is what is asked for if it has added value.

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News